The descriptive file provided for in Article L. 5138-1 and accompanying the declaration shall be sent to the Agence nationale de sécurité du médicament et des produits de santé by any means capable of acknowledging receipt. It includes the following information
1° Administrative information relating to the establishment where the activity of manufacturing, importing or distributing excipients is carried out, its internal organisation and, where applicable, its other activities and the certifications it holds in respect of its activities;
2° Technical information relating to the activities of manufacturing, importing or distributing excipients, in particular the list of these activities, the premises, equipment, processes and quality assurance system used to carry them out, as well as any subcontractors.
The list of this administrative and technical information is established by decision of the Director General of the Agency.
Amendments to the descriptive file are communicated to the Agency by any means enabling receipt to be acknowledged, in the form of an annual summary statement, in accordance with the procedures laid down by the aforementioned decision.